Butanixin

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FZ99TBX0LI. European Medicines Agency schedules Butanixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06004MIG. Butanixin generally arises in the molecular formula C16H18N2O2. The term BUTANIXIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, no. 10 1975, list 15.) BUTANIXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butanixin under HS 29333999 and SITC 51574. As of Q4 2014, BUTANIXIN remains the US FDA Preferred Term for this commodity. Butanixin bears US NLM identifiers UMLS ID C2347238 and NCI Concept Code C73082. SMILES: OC(=O)C1C(NC2CC(CCCC)CCC2)NCCC1.